202 related articles for article (PubMed ID: 332190)
1. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
Witzmann HK; Blechacz W
Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
[No Abstract] [Full Text] [Related]
2. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
3. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
Mikus P
Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
[TBL] [Abstract][Full Text] [Related]
4. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
Franzini C; Ferrante P
Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
[No Abstract] [Full Text] [Related]
5. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
Kauchtschischvili G; Nappi G; Bono G
Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
[No Abstract] [Full Text] [Related]
6. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
Holemans P
Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
[No Abstract] [Full Text] [Related]
7. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
[No Abstract] [Full Text] [Related]
8. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
Mikus P; Polák O; Ochsenreither AM
Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
[No Abstract] [Full Text] [Related]
9. [On the influence of vincamine on human cerebral blood flow in the acute test. Studies with 133Xe clearance method (author's transl)].
Kohlmeyer K
Arzneimittelforschung; 1977; 27(6a):1285-90. PubMed ID: 578454
[No Abstract] [Full Text] [Related]
10. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
Riccardi T; Passeri F; Locatelli F
Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
[TBL] [Abstract][Full Text] [Related]
11. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
12. [Vincamine in the therapy of cerebral vascular diseases in the aged].
De Candia O; Bartolucci E; Mancinella A; Baghiris D
Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
[No Abstract] [Full Text] [Related]
13. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
Lanfranchi M; Magnani G; Sinforiani E; Casali R
Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
Bartels H
MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
Schenker H
Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
[No Abstract] [Full Text] [Related]
16. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
Imre G; Németh B
Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
[No Abstract] [Full Text] [Related]
17. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
Ambrozi L; Bruck J; Tschabitscher H
Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
[No Abstract] [Full Text] [Related]
18. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
Maeda T
Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
[No Abstract] [Full Text] [Related]
19. [Treatment of circulatory encephalopathy with Cavinton].
Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
[No Abstract] [Full Text] [Related]
20. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
Bartels H
Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
